ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

French health officials received dozens of reports of syringe pricks at a public festival, sparking fear about HIV and ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...

U2 rock star Bono has been a prominent activist in the global fight against HIV/AIDS, including working with the George W.

Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest ...

HIV pharma leaders are at Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...

The Ghana HIV and AIDS Network (GHANET) is taking a proactive and strategic approach to combat the nation's HIV epidemic, focusing on a demographic often overlooked in health-seeking behaviours.

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

We’ve come a long way in treating HIV, the virus that can lead to AIDs. Just last month, the FDA approved a medication that ...

The World Health Organization (WHO) is recommending a twice-yearly injection of lenacapavir for prevention of HIV, according to a press release .